These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26557834)

  • 21. Anti-TNF strategies in stenosing and fistulizing Crohn's disease.
    Holtmann MH; Neurath MF
    Int J Colorectal Dis; 2005 Jan; 20(1):1-8. PubMed ID: 15459771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Influences on the Development of Fibrosis in Crohn's Disease.
    Verstockt B; Cleynen I
    Front Med (Lausanne); 2016; 3():24. PubMed ID: 27303667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical Therapy of Perianal Crohn's Disease.
    Klag T; Goetz M; Stange EF; Wehkamp J
    Viszeralmedizin; 2015 Aug; 31(4):265-72. PubMed ID: 26557835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of postoperative recurrence in fistulizing and stenotic Crohn's disease. a retrospective cohort study of 71 patients.
    Sachar DB; Subramani K; Mauer K; Rivera-MacMurray S; Turtel P; Bodian CA; Greenstein AJ
    J Clin Gastroenterol; 1996 Mar; 22(2):114-6. PubMed ID: 8742649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
    Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
    Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The multidisciplinary health care team in the management of stenosis in Crohn's disease.
    Gasparetto M; Angriman I; Guariso G
    J Multidiscip Healthc; 2015; 8():167-79. PubMed ID: 25878504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
    de Bruyn JR; Becker MA; Steenkamer J; Wildenberg ME; Meijer SL; Buskens CJ; Bemelman WA; Löwenberg M; Ponsioen CY; van den Brink GR; D'Haens GR
    PLoS One; 2018; 13(1):e0190999. PubMed ID: 29364909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic and medical management of fibrostenotic Crohn's disease.
    Thienpont C; Van Assche G
    Dig Dis; 2014; 32 Suppl 1():35-8. PubMed ID: 25531351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of fibrostenotic and fistulizing Crohn's disease.
    Schoepfer AM; Safroneeva E; Vavricka SR; Peyrin-Biroulet L; Mottet C
    Digestion; 2012; 86 Suppl 1():23-7. PubMed ID: 23051723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of CT enteroclysis with surgical pathology in Crohn's disease.
    Chiorean MV; Sandrasegaran K; Saxena R; Maglinte DD; Nakeeb A; Johnson CS
    Am J Gastroenterol; 2007 Nov; 102(11):2541-50. PubMed ID: 17900329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease behavior in adult patients: are there predictors for stricture or fistula formation?
    Dotan I
    Dig Dis; 2009; 27(3):206-11. PubMed ID: 19786742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost of Crohn's disease: drugs or surgery?
    Cohen RD
    BioDrugs; 2000 Nov; 14(5):331-44. PubMed ID: 18034577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK; McDonald JW
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Peyer's patches in the age-related incidence of Crohn's disease.
    Van Kruiningen HJ; Ganley LM; Freda BJ
    J Clin Gastroenterol; 1997 Sep; 25(2):470-5. PubMed ID: 9412954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscular Hyperplasia in Crohn's disease Strictures: Through Thick and Thin.
    Veisman I; Massey WJ; Goren I; Liu W; Chauhan G; Rieder F
    Am J Physiol Cell Physiol; 2024 Jun; ():. PubMed ID: 38912732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.
    Bettenworth D; Nowacki TM; Cordes F; Buerke B; Lenze F
    World J Gastroenterol; 2016 Jan; 22(3):1008-16. PubMed ID: 26811643
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.